|
1. Court grants Lilly injunction in lawsuit alleging $200M fraud scheme Full story
2. Next-gen GLP-1s target 3 key limitations: Report Full story
3. Precision genomics at scale: See what EHR integration, standardized workflows + AI make possible here.
4. Nonprofit buys remaining supply of experimental cancer drug, preserves patient access Full story
5. Lilly oral GLP-1 outperforms oral semaglutide in diabetes trial Full story
6. Are your AI agents making confident but wrong decisions? Find out here.
7. The 340B rebate fight escalates: 14 key developments Full story
8. Colorado wins FDA approval to import prescription drugs from Canada Full story
Becker’s Learning Opportunities
9. 5 forces reshaping cancer care: insights from Becker’s inaugural Oncology Executive Summit, here.
10. Rare cardiac disease pathways remain fragmented. See new survey insights here.
11. Building proprietary RCM AI is out of reach for most providers. See another path here.
12. Becker’s resources don’t stop here — explore more webinars and whitepapers.
Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.
|
.png)
